Neuromod Devices announced today that it closed a $33.2 million (€30 million) financing round to support its tinnitus treatment device. Dublin, Ireland–based Neuromod Devices develops Lenire, a neuromodulation device for reducing tinnitus severity. The system received FDA de novo approval in March and has availability throughout Europe. Lenire delivers mild electrical pulses to the tongue […]
Neuromod Devices
Lenire non-invasive neuromod for tinnitus wins FDA de novo nod
Neuromod Devices announced that the FDA granted de novo approval to its Lenire neuromodulation device for treating tinnitus. According to a news release, Lenire becomes the first bimodal neuromodulation device of its kind to receive FDA approval for treating tinnitus. “Lenire’s approval not only means that millions of Americans living with tinnitus can get the […]
Neuromod Devices appoints Elsaesser as CCO
Non-invasive neuromodulation technology developer Neuromod Devices announced today that it is appointing Florian Elsaesser as its new chief commercial officer. Elsaesser is a 12-year veteran in the space, having worked extensively in the hearing aid industry, according to a news release. He previously held executive positions at Sivantos and Siemens (NYSE:SI) Audiology. Dublin-based Neuromod Devices said […]
Eko raises $20m Series B for smart cardiac monitor | Funding Roundup, September 26, 2019
Eko said yesterday that it raised a $20 million Series B round for the smart cardiac monitor it’s developing. The San Francisco-based company is working on machine learning technology for a combined digital stethoscope and electrocardiogram, designed for both clinical and at-home monitoring. Eko said more than 3,000 hospitals worldwide use its platform, treating millions […]
Siemens Healthineers taps ex-Abbott Vascular prez Nath to lead lab diag biz | Personnel Moves January 30, 2018
Siemens (NYSE:SI) Healthineers said today it tapped former Abbott (NYSE:ABT) Vascular president Dr. Deepak Nath as its new laboratory diagnostics business president, taking over for Franz Walt who operated as president from 2014 to 2017. Nath spent 10 years with Abbott, serving most recently as its vascular division president and as an executive officer of the company, and […]
Neuromod raises $6.2m in Series A
Neuromod said today it raised $6.2 million (EU€5.5 million) in a Series A round of financing, with fund slated to support its mutebutton bi-modal neuromodulation device for patients with chronic tinnitus. Funds from the round came from venture capital firm Fountain Healthcare Partners, the Dublin-based company said. “Neuromod is delighted to announce this investment, which […]
Neuromod gains CE Mark approval for tinnitus device | Regulatory news for the week of December 1, 2014
Neuromod wins CE Mark for tinnitus device
Dublin-based Neuromod Devices said it won CE Mark approval in the European Union for its new multi-sensory device to treat tinnitus, also known as “ear-ringing.”
The product, mutebutton, is a handheld device that helps the brain distinguish between real and phantom noises through audio and tongue stimulation.
